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Abstract
Background/Aims: Alpha-synuclein (α-Syn) is a neuronal protein that is highly implicated in 
Parkinson’s disease (PD), and protein phosphatase 2A (PP2A) is an important serine/threonine 
phosphatase that is associated with neurodegenerative diseases, such as PD. α-Syn can 
directly upregulate PP2A activity, but the underling mechanism remains unclear. Therefore, 
we investigated the molecular mechanism of α-Syn regulating PP2A activity. Methods: α-Syn 
and its truncations were expressed in E.coli, and purified by affinity chromatography. PP2A 
Cα and its mutants were expressed in recombinant baculovirus, and purified by affinity 
chromatography combined with gel filtration chromatography. The interaction between 
α-Syn and PP2A Cα was detected by GST pull-down assay. PP2A activity was investigated 
by the colorimetric assay. Results: The hydrophobic non-amyloid component (NAC) domain 
of α-Syn interacted with PP2A Cα and upregulated its activity. α-Syn aggregates reduced its 
ability to upregulate PP2A activity, since the hydrophobic domain of α-Syn was blocked during 
aggregation. Furthermore, in the hydrophobic center of PP2A Cα, the residue of I123 was 
responsible for PP2A to interact with α-Syn, and its hydrophilic mutation blocked its interaction 
with α-Syn as well as its activity upregulation by α-Syn. Conclusions: α-Syn bound to PP2A Cα 
by the hydrophobic interaction and upregulated its activity. Blocking the hydrophobic domain 
of α-Syn or hydrophilic mutation on the residue I123 in PP2A Cα all reduced PP2A activity 
upregulation by α-Syn. Overall, we explored the mechanism of α-Syn regulating PP2A activity, 
which might offer much insight into the basis underlying PD pathogenesis.
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Introduction
Alpha-synuclein (α-Syn), encoded by the SNCA gene [1-3], contributes to brain 
neuroplasticity and neurodegeneration, which is implicated as being causative factor for 
neurodegenerative disorders, including Parkinson’s disease (PD), dementia with Lewy bodies 
(DLB), as well as multiple system atrophy (MSA) [4-6]. α-Syn is abundantly expressed in the 
central nervous system, mainly at presynaptic terminal in mammalian brains. Structurally, 
α-Syn can usually be divided into three parts: the N terminus (residues 1-60), which contain 
four 11-amino acid imperfect repeats (coding for amphipathic α-helices) with a conserved 
motif (KTKEGV); the central hydrophobic non-amyloid component (NAC, residues 61-95), 
which contain three additional KTKEGV repeats; and the C terminus (residues 96-140), in 
which acidic residues and prolines are highly enriched [7-9]. The N terminus, with lipid-
binding motifs KTKEGV, is predicated to form α-helical structure for interaction with lipidic 
membranes [7, 10, 11]. Most of the mutants associated with PD, such as A53T, exist in this 
region [12]. The NAC domain is responsible for its misfolding and aggregation [8, 13]. The C 
terminus is thought to contain protein-protein and protein-small molecule interaction sites 
[14-16]. α-Syn not only regulates the release of neurotransmitters, but also regulates the 
activity of many proteins, such as protein phosphatase 2A (PP2A)[17-19]. 
PP2A is an important serine/threonine phosphatase, and it is comprised of three 
subunits: a 65-kD structural subunit A, a variable regulatory subunit B, and a 36-kD 
catalytic subunit C [20-25], and the subunit C has a unique catalytic activity. PP2A can 
directly dephosphorylate numerous substrates, such as tyrosine hydroxylase (TH) [26, 
27], extracellular-regulated kinases (ERK1/2) [28], and tau protein [29-31]. PP2A is a 
key regulator in neurodegenerative diseases [32-36]. In Alzheimer’s disease (AD), the 
downregulation of PP2A activity could increase the phosphorylation of tau protein, raise the 
formation of amyloid precursor protein, and increase the missing of neurons [37-39]. In PD, 
the upregulation of PP2A activity could reduce the phosphorylation of TH, which leads to the 
decrease of dopamine [17].
Previous studies showed that α-Syn could upregulate the activity of PP2A which further 
reduce TH phosphorylation in dopaminergic cells [17, 40], but the underlying structural 
mechanism of α-Syn regulating PP2A activity remains unclear.
In this study, to gain insight into the precise manner by which α-Syn bind to PP2A to 
stimulate its activity, we proposed a hypothesis that α-Syn could bind to PP2A Cα by the 
hydrophobic interaction and then upregulate its activity. To confirm our hypothesis, we 
firstly constructed α-Syn truncates, and found that the NAC domain of α-Syn interacted with 
PP2A Cα and upregulated PP2A activity. Second, after blocking the NAC domain by forming 
α-Syn aggregates, we found α-Syn aggregates less stimulated PP2A activity than monomers. 
Finally, we defined the definite residue within PP2A Cα which was responsible for its 
interaction with α-Syn, and its association with PP2A activity regulation by α-Syn. In short, 
the data showed that NAC domain of α-Syn could bind to the hydrophobic center of PP2A Cα, 
particularly the residue I123, to stimulate PP2A activity. These results might offer insight 
into the mechanistic basis of PD pathogenesis.
Materials and Methods
Plasmid constructs
The cDNA encoding the α-Syn and its truncates were subcloned into the pCMV-myc vector. The 
mutants of α-Syn (A53T) and PP2A Cα (I123S, W200S, L243S, Y265S and C269S) were performed using 
the PCR-based Quik Change method of site-directed mutagenesis with Phusion DNA polymerase (Agilent 
Technologies). These mutations were confirmed by sequencing the entire coding region.
To make α-Syn-GLuc constructs, α-Syn was subcloned into the fragments of humanized Gaussia 
princeps luciferase (1-93; 94-169) to generate α-Syn-GLuc-N and α-Syn-GLuc-C fusion constructs. For the 
A53T-GLuc-N and A53T-GLuc-C fusion constructs, they were generated by the similar method.
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Cell cultures and transfection
Human SK-N-SH neuroblastoma cells obtained from the American Type Culture Collection were grown 
in Dulbecco’s Modified Eagle’s Medium (DMEM, Gibco) supplemented with 10% fetal bovine serum (FBS, 
Gibco) at 37°C under 5% CO
2
. The transient transfections were performed by lipofection with polyetherimide 
(PEI, Polysciences).
Western blot
After transfection, cells were washed with ice-cold phosphate-buffered saline (PBS, Origene) and 
homogenized them in ice-cold lysis buffer (15 mM Tris, 0.25 M sucrose, 2 mM EDTA, 1 mM EGTA, 10 mM 
Na
3
VO
4
, 25 mM NaF, 10 mM sodium pyrophosphate, and protease inhibitor, pH 7.6) for 30 min. Then 
homogenates were centrifuged at 12, 000 g for 30 min and the supernatant fraction was collected for 
analysis. The protein concentration was determined using a bicinchoninic acid protein assay kit (Pierce 
Biotechnology) according to the manufacturer’s instructions. The samples were resolved on 10% SDS 
polyacrylamide gels and transferred to PVDF membranes (Millpore). The membranes were probed with 
the following primary antibodies: mouse anti-β-actin (1:2, 000, GuanXingYu), mouse anti-α-Syn (1:2000, 
BD), mouse anti-myc (1:5000, Clontech). These primary antibodies were revealed by infrared-conjugated 
IgG IRDye 680RD (1:10000, LI-COR Bioscience) or 800CW (1:10000, LI-COR Bioscience). Protein bands 
were detected using an Odyssey Infrared Imaging system (LI-COR Bioscience), and analyzed with Image J 
software (imagej.nih.gov/ij/).
Immunofluorescence and confocal microscopy
24 h after transfection with the indicated plasmids, SK-N-SH cells were washed with PBS, fixed with 
4% paraformaldehyde for 20 min, washed in PBS again, and permeabilized with 0.3% Triton X-100 in PBS 
for 25 min at room temperature. After blocking with 10% normal goat serum for 1 h, cells were incubated 
with mouse anti-myc (1:2000, Clontech) overnight at 4°C, followed by incubation with Alexa Fluor 
488-conjugated secondary antibody (1:500, Life Technologies) for 1 h at room temperature. Cell nuclei were 
visualized by staining with DAPI (1:1000, Sigma). The cells were imaged using a confocal microscope (Leica 
Microsystems).
Protein expression and purification
The cDNA encoding full-length α-Syn and its truncates were subcloned into pGEX4T-1 vector 
(Invitrogen), and expressed in E.coli strain BL21 cells. 0.1 mM Isopropyl β-D-galactopyranoside (IPTG) was 
added to bacterial cultures grown at 27°C. The lysates were centrifuged at 12, 000 g for 40 min, then the 
supernatants were incubated with glutathione-sepharose 4B beads (GE Healthcare) at 4°C. After 3 h, the 
beads were collected and washed 3 times. The GST fusion proteins were eluted by buffer containing 50 mM 
Tris-HCl and 10 mM reduced glutathione (pH 8.0). The purified GST fusion proteins were stored at -80°C.
The cDNA encoding PP2A Cα and its mutants were subcloned into pFastbac vector (Invitrogen), 
transformed into E.coli strain DH10Bac cells, and isolated the recombinant bacmid DNA. Then transfect 
recombinant bacmid DNA into SF9 cells, harvest the recombinant baculovirus, and express the baculovirus 
in SF9 cells. The cell lysates were harvested 3 days after infection with P2 baculovirus, and centrifuged at 
12, 000 g for 15 min, then the supernatants were incubated with Ni-Sepharose 6 beads (GE Healthcare) at 
4°C. After 2.5 h, the beads were collected and washed 3 times. The His fusion proteins were eluted by buffer 
containing 50 mM sodium phosphate, 300 mM NaCl and 300 mM imidazole (pH 7.0). Then, the protein 
was further purified by gel filtration through a Superdex 75 column, during which the imidazole had been 
desalted, and the buffer was exchanged into Tris buffer (50 mM Tris-HCl, pH 8). The purified His fusion 
proteins were finally concentrated by Amicon Ultra-4 Centrifugal Filter Devices (Merck Millipore) and 
stored at -80°C.
PP2A activity assay
The activity of PP2A was measured using a PP2A Colorimetric Assay kit (GenMed Scientifics Inc). This 
assay is based on the release of free phosphate during the dephosphorylation of RKpTIRR by endogenous 
PP2A, detected by a chromogenic reaction with molybdenum blue produced by a ferrous sulfate reduction. 
In brief, samples were incubated for 20 min at 30℃ in the assay buffer containing 50 mM Tris-HCI pH 8, 
0.1 mg/ml BSA, 1 mM β-mecaptoethanol (BME) and 40 µM substrate RKpTIRR. To terminate the reaction, 
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molybdenum blue solution was added to the mixture. The mixture was incubated for 15 min at 30℃ to allow 
color development. The free phosphate concentration was measured at 660 nm using a spectrophotometer 
(Bio-Rad), and the phosphate concentration was converted to PP2A activity/mg protein as described in the 
instructions.
GST pull-down assay
The GST pull-down assays were carried out as described [41, 42]. In brief, the proteins with GST tag 
were incubated with glutathione beads for 1 h at 4°C, and washed 5 times with PBS. Then PP2A Cα or its 
mutants were subjected to GST pull-down with GST or GST fusion proteins for 3 h at 4°C. The products 
were centrifuged at 1000 g for 5 min at 4°C. Samples were washed 5 times with PBS. After the final wash, 
glutathione-bound proteins were eluted by adding of loading buffer and boiling for 10 min. Eluted proteins 
were separated by SDS-PAGE gels with the corresponding antibodies, such as mouse anti-His (1:5000, 
Clontech) and mouse anti-GST (1:10000, Novagen).
Transmission electron microscopy (TEM)
α-Syn aggregates were fixed on Formvar coated copper grids for 2 min, stained with 2% uranyl acetate 
solution for 5 min, washed in 0.1 M PBS for 3 times, air dried, and observed by a JEOL transmission electron 
microscope.
Protein-fragment complementation assay
Fusion constructs for α-Syn (α-Syn-GLuc-N, α-Syn-GLuc-C), and for A53T (A53T-GLuc-N, A53T-GLuc-C) 
were generated and the respective paired constructs were transfected into SK-N-SH cells in a 96-well plate 
format. 24 h after transfection, cells were washed with PBS and replaced with phenol-red free medium. 
Luciferase activity from protein complementation was measured for live cells in an automated plate reader 
at 480 nm following the injection of the cell permeable substrate, coelenterazine (20 μM) (Sigma) with a 
signal integration time of 2 s.
Computational docking
The computational model of the interaction between α-Syn to PP2A Cα was accomplished using online 
protein-protein dock server, ZDOCK 3.0.2 (http://zdock.umassmed.edu/). The amino acid sequences of 
human α-Syn (PDBID: 1XQ8) and PP2A Cα (PDBID: 2IAE chain C) were downloaded from the NCBI website, 
and uploaded to the server. The final image of the model was downloaded and visualized by Discovery 
Studio Visualizer 4.0 (BIOVIA, San Diego, CA, USA).
Statistics
Statistical analyses were performed using Prism software, version 6 (GraphPad). Differences between 
groups were assessed by ANOVA. Data are expressed as mean ± SEM for at least three independent 
experiments, and significance was considered when p value was less than 0.05.
Results
α-Syn directly interacted with PP2A Cα and upregulated its activity
Previous studies have shown that α-Syn could interact with PP2A Cα and upregulate 
PP2A activity [17, 40]. To reproduce this effect, we firstly expressed and purified these 
two proteins. α-Syn, with GST tag, was expressed in E.coli, and then purified by affinity 
chromatography with glutathione-sepharose beads (Fig. 1A). For PP2A Cα, it was expressed 
in recombinant insect baculovirus, and then purified by affinity chromatography with Ni-
sepharose beads combined with gel filtration chromatography (Fig. 1B). In order to confirm 
the direct interaction between α-Syn and PP2A Cα, we performed GST pull-down assay after 
incubation of these two purified proteins. As shown in Fig. 1C, α-Syn pulled down PP2A Cα, 
while no signal was observed in the GST group as control, demonstrating that α-Syn could 
directly interact with PP2A Cα.
Subsequently, we detected the effect of α-Syn on PP2A activity. For this purpose, α-Syn 
protein was firstly obtained by cleaving the GST tag from the fusion protein of α-Syn/GST 
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(Fig. 1A). Then α-Syn protein (0.5 mg/ml) was incubated with PP2A Cα (0.5 mg/ml), and 
PP2A activity was measured by colorimetric assay. As shown in Fig. 1D, the PP2A activity 
in response to α-Syn was two-fold higher than the baseline PP2A activity, which implied 
that α-Syn could upregulate PP2A activity. To further confirm the above results in cells, the 
plasmids pCMV-myc-α-Syn and the empty plasmids pCMV-myc were transiently transfected 
into SK-N-SH cells respectively. First, the protein level of α-Syn was detected by western 
blotting to make sure they were at comparable level. (Fig. 1E). Then the effect of α-Syn on 
PP2A activity was detected. The results showed that the PP2A activity in α-Syn-transfected 
group was larger than that in blank vector group and non-treatment group, which suggested 
that α-Syn could upregulate PP2A activity in cells (Fig. 1F). Together, the results indicated 
that α-Syn could directly interact with PP2A Cα and upregulate its activity.
The NAC domain of α-Syn directly interacted with PP2A Cα
α-Syn is usually divided into three domains: the N terminus (residues 1-60), the NAC 
domain (residues 61-95), and the C terminus (residues 96-140) (Fig. 2A) [7, 8, 43]. Since 
the above experiments indicated that α-Syn could directly interact with PP2A Cα, we 
questioned which terminus of α-Syn was associated with its interaction with PP2A Cα. To 
address this question, α-Syn truncates were constructed, expressed in E.coli, and purified 
by affinity chromatography with glutathione-sepharose beads (Fig. 2B). Then we detected 
the interaction between α-Syn truncates and PP2A Cα by GST pull-down assay. The results 
showed that the NAC domain of α-Syn pulled down PP2A Cα, while the N terminus and C 
terminus could not (Fig. 2C). Statistically, the level of PP2A Cα, pulled down by the NAC 
domain and full length α-Syn, were significantly higher compared with the other groups (Fig. 
2D). To further confirm this observation, we then replaced the NAC domain of α-Syn with the 
homologous region from β-Syn to get the chimera α-Syn-NAC-swap. Since it demonstrated 
that the NAC domain was responsible for α-Syn to interact with PP2A Cα, we hypothesized 
that the chimera α-Syn-NAC-swap should not exhibit its interaction with PP2A Cα. Indeed, 
our GST pull-down experiment indicated that the chimera α-Syn-NAC-swap could not pull 
down the protein of PP2A Cα (Fig. 2E-F). Together, these results suggested the NAC domain 
of α-Syn could directly interact with PP2A Cα.
The NAC domain of α-Syn was responsible for the PP2A activity regulation
Since the NAC domain of α-Syn could directly interact with PP2A Cα, then we asked if 
it could also upregulate the activity of PP2A. For this purpose, the purified α-Syn truncated 
proteins (0.5 mg/ml) were incubated with PP2A Cα (0.5 mg/ml) respectively, then PP2A 
activity was measured by colorimetric assay. As shown in Fig. 3A, the PP2A activity in the 
Fig. 1. α-Syn interacted with PP2A Cα and upregulated 
its activity. (A-B) The purified α-Syn protein (A) and PP2A 
Cα protein (B) were detected by the coomassie brilliant 
blue (CBB) staining of SDS-PAGE gels. (C) The interaction 
between α-Syn and PP2A Cα was detected by GST pull-
down assay. Purified α-Syn protein was incubated with 
PP2A Cα protein, then the compounds were separated by 
SDS-PAGE gels. Anti-His and anti-GST blots showed input 
and pull-down fractions in GST pull-down assay. Input, 
PP2A Cα. (D) Purified α-Syn protein was incubated with 
PP2A Cα for 0.5 h, then PP2A activity was detected using 
colorimetric assay. **p<0.01, n=5. (E) The plasmids pCMV-
myc-α-Syn and pCMV-myc were transiently transfected 
into SK-N-SH cells for 24 h. The protein level of α-Syn 
was detected by western blotting. β-actin was used as a 
loading control (F) 24 h after plasmid transfection into 
SK-N-SH cells, the PP2A activity regulation by α-Syn was detected by colorimetric assay. **p<0.01, n=5.
1 
 
Fig.1 
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groups of α-Syn and α-Syn-NAC was higher than the baseline PP2A activity, while the PP2A 
activity in the group of α-Syn-N and α-Syn-C was similar with the baseline. These data implied 
that the NAC domain of α-Syn could upregulate PP2A activity, but the N and C terminus had 
almost no effect on PP2A activity.
To further confirm the effect of α-Syn truncations on PP2A activity in cells, the 
plasmids encoding α-Syn truncations were transiently transfected into SK-N-SH cells. 
First, the expression level of α-Syn truncations in transfected cells was confirmed by 
immunocytochemistry (Fig. 3B) and dot blotting (Fig. 3C). Then PP2A activity in transfected 
cells was measured by the colorimetric assay, and the results showed that the PP2A activity in 
full length α-Syn and α-Syn-NAC-transfected cells were larger than that in vector-transfected 
cells, while the PP2A activity in the α-Syn-N and α-Syn-C-transfected cells was similar 
Fig. 2. The NAC domain of α-Syn interacted with 
PP2A Cα. (A) The model of α-Syn truncations. (B) The 
purified proteins of α-Syn truncations were detected 
by CBB staining of SDS-PAGE gels. (C) GST pull-
down assay was performed to detect the interaction 
between α-Syn truncations and PP2A Cα. Purified 
α-Syn truncates were incubated with PP2A Cα, then 
the compounds were separated by SDS-PAGE gels. 
Anti-His and anti-GST blots showed input and pull-
down fractions in GST pull-down assay. Input, PP2A 
Cα. (D) Quantitative analysis of the percentage 
of PP2A Cα pull-down by α-Syn truncations was 
performed. (E) After replacing the NAC domain of 
α-Syn with the homologous region from α-Syn to 
get the chimera α-Syn-NAC-swap, the interaction 
between this chimera and PP2A Cα was analyzed by 
GST pull-down assay. The purified chimera protein 
α-Syn-NAC-swap was incubated with PP2A Cα, then 
the compounds were separated by SDS-PAGE gels. 
Anti-His and anti-GST blots showed input and pull-
down fractions in GST pull-down assay. Input, PP2A 
Cα. (F) Quantitative analysis of the percentage of PP2A Cα pull-down by α-Syn-NCA-swap was performed. 
**p<0.01, n=5.
2 
 
Fig. 2 
 
Fig. 3. The NAC domain of α-Syn upregulated the 
activity of PP2A. (A) The purified full length α-Syn 
and its truncations were incubated with PP2A 
Cα for 0.5 h, then PP2A activity was detected by 
colorimetric assay. **p<0.01, n=5. (B) The plasmids 
of α-Syn and its truncations (pCMV-myc-α-Syn, 
pCMV-myc-α-Syn-N, pCMV-myc-α-Syn-M, pCMV-
myc-α-Syn-C) were transfected into SK-N-SH cells 
respectively. After transfection 24 h, cells were 
fixed and stained with anti-myc antibodies (green). 
The nucleus was stained by DAPI (blue). Scale 
bar, 25 μm. (C) The protein level of α-Syn and its 
truncations in SK-N-SH cells was detected by dot 
blotting after transfection for 24 h. (D) 24 h after 
transfection of α-Syn and its truncation plasmids 
into SK-N-SH cells, PP2A activity was detected by 
colorimetric assay. **p<0.01, n=5.
3 
 
Fig.3
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with that in vector-transfected group (Fig. 3D). The above results suggested that the NAC 
domain of α-Syn, like the full length of α-Syn, could upregulate PP2A activity, while the N and 
C terminus could not. These data confirmed that the NAC domain of α-Syn, containing the 
hydrophobic amino acid, was responsible for regulating PP2A activity, which was consistent 
with the results in vitro.
Blocking the NAC domain of α-Syn declined its regulating effect on PP2A activity
Since the NAC domain of α-Syn could upregulate PP2A activity, we hypothesized that 
blocking the NAC domain might decline its regulating effect on the activity of PP2A. As we 
know, α-Syn is a natively unfolded protein with a tendency to aggregate by the hydrophobic 
interaction [8, 13, 44]. After aggregation, the hydrophobic domain of α-Syn may be blocked, 
so α-Syn aggregates should less upregulate the PP2A activity than monomers. To test our 
hypothesis, α-Syn aggregates were firstly generated from purified recombinant α-Syn in 
vitro at 37°C for 72 h with continuous shaking. Electron microscope imaging further verified 
the morphology of α-Syn aggregates, and the results showed α-Syn aggregates were large, 
broad and had a ribbon-like shape fibrils, but the fibril-like structure were not detected in 
α-Syn monomer sample (Fig. 4A). Then the PP2A activity in response to α-Syn aggregates 
was measured by colorimetric assay, and the results showed that PP2A activity response to 
α-Syn aggregates was much lower than that of α-Syn monomers, indicating that aggregates 
could less stimulate PP2A activity than monomers (Fig. 4B).
Next, we further confirm that α-Syn aggregates less stimulated the PP2A activity 
than monomers in cells. A53T, the first mutant of α-Syn associated with PD, had a more 
propensity to form aggregates [45], and we also further confirmed that A53T mutant could 
form aggregates more efficiently than WT α-Syn in vitro (Fig. 4C). So, we speculated that 
A53T could less upregulate PP2A activity in cells, compared with wild type (WT) α-Syn. In 
this scenario, we first adopted a protein-fragment complementation assay (PCA) to prove 
that A53T was more prone to aggregate than WT α-Syn. For this purpose, WT α-Syn or A53T 
mutant were fused to the amino-terminal (1-93) or carboxy-terminal (94-169) fragments of 
Gaussia princeps luciferase (GLuc) respectively [46], to generate α-Syn-GLuc-N, α-Syn-GLuc-C 
or A53T-GLuc-N, A53T-GLuc-C constructs. The two paired fusion proteins could reconstitute 
when brought together during α-Syn aggregation [47, 48] (Fig. 5A). So the SK-N-SH cells may 
be transfected with these paired constructs for analysing the α-Syn aggregation level. First, 
to evaluate the expression level of these proteins, we adopted the western blotting and the 
results indicated that the levels of these proteins were similar on immunoblots (Fig. 5B). After 
Fig. 4. α-Syn aggregates could less stimu-
late PP2A activity than monomers. (A) 
Electron microscope images of α-Syn 
monomers (the upper) and aggregates 
(the lower). Scale bar, 200 nm. (B) α-Syn 
aggregates and monomers were incu-
bated with PP2A Cα for 0.5 h respectively, 
then PP2A activity was detected in vi-
tro by colorimetric assay kit. (C) Kinetic 
analysis of the aggregation of α-Syn and 
its mutant A53T using thioflavin T (ThT) 
fluorescence assay. α-Syn and its mutant 
A53T proteins were dissolved to a con-
centration of 360 µM (around 5 mg/mL) 
respectively in the assembly buffer (50 
mM Tris/100 mM NaCl, pH 7.0). The re-
action mixtures were incubated at 37°C with constant agitation (1000 rpm) for two days and the rate of ag-
gregation was monitored using the ThT fluorescence assay (excitation at 450 nm, 2.5 nm slit, and emission 
at 480 nm, 5 nm slit). **p<0.01, n=5.
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injection of cell permeable substrate, we 
analyzed the aggregation level by PCA 
assay. The results showed the luciferase 
activity of cells cotransfected with A53T-
GLuc-N/C was larger than that of cells 
cotransfected with α-Syn-GLuc-N/C (Fig. 
5C). These date suggested A53T was more 
prone to aggregate than WT α-Syn.
Since A53T was more prone to 
aggregate than WT α-Syn, we then tested 
our hypothesis that A53T could less 
stimulate PP2A activity than WT α-Syn 
in cells. The plasmids pCMV-myc-α-Syn 
and pCMV-myc-A53T were transfected 
into SK-N-SH cells respectively, and 
the expression level of WT α-Syn and 
A53T in transfected cells was first 
confirmed to be at the comparable level 
by immunocytochemistry (Fig. 6A) and 
western blotting (Fig. 6B). Then we 
measured PP2A activity in transfected 
cells, and the results showed that the PP2A 
activity in cells transfected with A53T was 
lower than that in cells transfected with 
WT α-Syn (Fig. 6C). These results implied 
that A53T less stimulated PP2A activity 
than WT α-Syn in cells.
Certainly, for this effect that A53T 
less stimulated PP2A activity than WT 
α-Syn in cells, there are two possibilities: 
one possibility is that A53T mutation 
per se has less effect on PP2A activity 
upregulation, and the other possibility 
is that A53T forms more aggregates and 
consequently blocks the hydrophobic 
domain of α-Syn which is associated 
with the PP2A activity upregulation. 
Thus, we have to exclude one possibility 
from the other. To test the effect of A53T 
mutation per se on the PP2A activity, we 
first expressed and purified A53T protein 
(Fig. 7A). WT α-Syn and A53T proteins 
were incubated with PP2A Cα protein 
respectively, and the results showed that 
the PP2A activity in response to purified 
A53T protein was similar with that of WT 
α-Syn (Fig. 7B). These results indicated 
that A53T mutation per se had similar 
regulating effect on PP2A activity with 
WT α-Syn, and the effect that A53T less 
stimulated PP2A activity than WT α-Syn 
in cells may be due to the formation of 
more aggregates in A53T transfecting 
cells.
Fig. 5. A53T was more prone to aggregate than 
WT α-Syn. (A) The principle of protein-fragment 
complementation assay based on Gaussia princeps 
luciferase. (B) The protein levels, after paired constructs 
transfected into SK-N-SH cells, were detected by 
western blotting. β-actin was used as a loading control. 
(C) 24 h after transfection, the cells were washed and 
treated with the substrates (coelenterazine, 20 μM). 
The luciferase activity was measured in an automated 
plate reader at 480 nm. **p<0.01, n=5.
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Fig. 6. A53T less stimulated the activity of PP2A 
than WT α-Syn in cells. (A) The plasmids of α-Syn 
(pCMV-myc-α-Syn) and A53T (pCMV-myc-A53T) were 
transfected into SK-N-SH cells. After transfection 24 
h, SK-N-SH cells were fixed and stained with anti-
myc antibodies (green). The nucleus was stained by 
DAPI (blue). Scale bar, 25 μm. (B) Western blotting 
was performed to determine α-Syn and A53T protein 
expression levels in transfected SK-N-SH cells. β-actin 
was used as a loading control. (C) 24 h after transfection 
with plasmids into SK-N-SH cells, PP2A activity was 
detected by colorimetric assay. *p<0.05, n=5.
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Together, the above results suggested that blocking the NAC domain of α-Syn declined 
the upregulating effect on PP2A activity. In other words, the NAC domain was involved in the 
process of α-Syn regulating PP2A activity.
The residue I123 in PP2A Cα played a role in its activity upregulation by α-Syn
Since the NAC domain of α-Syn interacted with PP2A Cα and upregulated its activity, 
but it is not clear which site of PP2A Cα is responsible for its interaction with α-Syn. There 
is a hydrophobic region in PP2A Cα [21], since our results showed that the hydrophobic 
domain of α-Syn (NAC) could bind to PP2A Cα, we hypothesized that α-Syn might bind to 
the hydrophobic region of PP2A Cα and upregulate its activity. To test our hypothesis, the 
computational molecular docking was firstly performed to imitate the potential interaction 
between α-Syn and PP2A Cα. The docking results showed that the interaction was mainly 
clustered in the vicinity of I123 in PP2A Cα and the end of the NAC terminus of α-Syn (Fig. 8).
In order to further experimentally identify which site are responsible for PP2A Cα 
upregulation by α-Syn, five amino acids in the hydrophobic region of PP2A Cα were mutated 
to hydrophilic acid, resulting in mutants I123S, W200S, L243S, Y265S and C269S (Fig. 
9A). These mutants were expressed in 
recombinant insect baculovirus, and 
purified by affinity chromatography with 
Ni-sepharose beads combined with gel 
filtration chromatography (Fig. 9B). Then 
these mutant proteins were respectively 
incubated with α-Syn, and the interaction 
was detected by the GST pull-down assay. 
As shown in Fig. 9C, the mutants of PP2A 
Cα (including W200S, L243S, Y265S and 
C269S) were pulled down by α-Syn, except 
I123S. These results implied that the 
I123 of PP2A Cα might be critical residue 
mediating the interaction between α-Syn 
and PP2A Cα.
Since PP2A Cα I123S could not bind 
to α-Syn, we hypothesized α-Syn might 
have less effect on its activity stimulation. 
So the purified α-Syn protein (0.5 mg/
ml) and PP2A Cα I123S (0.5 mg/ml) 
were incubated in vitro, and then PP2A 
activity in response to α-Syn was detected 
by the colorimetric assay. The results 
showed that the PP2A Cα I123S activity 
in response to α-Syn was similar with the 
baseline activity (Fig. 9D). Here, there are 
two possibilities for this observation: one 
possibility is that I123S mutation per se 
has effect on its activity, and the other 
possibility is that α-Syn does not interact 
with I123S and consequently block the 
PP2A activity regulation by α-Syn.
In order to exclude the effect of 
mutant (I123S) of PP2A Cα per se on 
its activity, we compared the activity 
of PP2A Cα I123S and WT PP2A Cα. As 
shown in Fig. 9D, the activity of I123S was 
comparable as the baseline PP2A activity. 
Fig. 7. A53T protein showed similar effect on PP2A 
activity with WT α-Syn. (A) Purified A53T protein 
was detected by the CBB staining of SDS-PAGE gels. 
(B) Purified A53T protein and WT α-Syn protein were 
incubated with PP2A Cα for 0.5 h respectively, then 
PP2A activity was detected in vitro by the assay kit. 
**p<0.01, n=5.
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Fig. 8. The 
computational 
docking model 
i l l u s t r a t e s 
the potential 
i n t e r a c t i o n 
between α-Syn 
and PP2A Cα. (A) 
The interaction 
between α-Syn 
(red) and PP2A 
Cα (cyan). The 
intermolecular 
non-bond interaction between these two proteins were 
identified by using the Discovery Studio Visualizer. The 
interaction is mainly clustered in the vicinity of ILE123 
of PP2A Cα and the end of the NAC domain of α-Syn. (B) 
The close view of the interaction between α-Syn and 
PP2A Cα.
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In other words, I123S per se could not affect 
the PP2A activity. The above results together 
suggested that the residue I123 in PP2A Cα 
might play a role in its binding with α-Syn and 
its activity upregulation, although we could not 
exclude other residues which were potential for 
this effect.
Discussion
In this study, we explored the molecular 
mechanism of α-Syn regulating PP2A activity. 
We found the NAC domain of α-Syn could 
interact with PP2A Cα and increased its activity. 
When the NAC domain was blocked during 
α-Syn aggregation, α-Syn showed little effect 
on PP2A activity upregulation. In addition, we 
found the residue I123 of PP2A Cα might play a 
role in its activity regulation by α-Syn. Together, 
these results implied that α-Syn might bind 
to PP2A Cα by hydrophobic interaction and 
upregulate PP2A activity, and α-Syn aggregates 
could less stimulate the PP2A activity than 
α-Syn monomers. These findings could be best 
illustrated in Fig. 10 in terms of the protein 
binding pattern and PP2A activity regulation.
We found that the NAC domain of α-Syn 
could interact with PP2A Cα, but the N terminus 
and C terminus could not. From theoretical 
perspective, the NAC terminus of α-Syn is a 
hydrophobic region, and it can bind to many 
moleculars and regulate their activity [6, 9, 44]. 
Here, we found that the NAC domain of α-Syn 
could interact with PP2A Cα and upregulate its 
activity. On the other side, PP2A is an important phosphatase, and the hydrophobic region of 
PP2A Cα plays a chief role in its activity regulation. As is known, there is also a hydrophobic 
region in PP2A Cα. Previous studies have shown that okadaic acid, an inhibitor of PP2A, 
could bind to the hydrophobic region of PP2A Cα to inhibit its activity. Further, from the 
homology model, the interaction between α-Syn and PP2A Cα was mainly clustered in the 
NAC domain of α-Syn and the vicinity of I123 of PP2A Cα. So we hypothesized that the NAC 
domain of α-Syn might bind to the hydrophobic region of PP2A Cα. Experimentally, our data 
indeed showed that the NAC domain of α-Syn could bind to the hydrophobic region of PP2A 
Cα and upregulate its activity, particularly the residue I123 of PP2A Cα.
α-Syn is a natively unfolded protein which is prone to aggregate, and α-Syn aggregates 
are formed by the NAC domain which mediates the conformational changes from random 
coil to a β-sheet structure [6]. Aggregated α-Syn is the major component of inclusions in PD 
and other synucleinopathy brains, which indicates that α-Syn aggregation is relevant to the 
pathogenesis of neurodegenerative diseases [8, 49]. We found α-Syn aggregates, blocking 
the NAC domain, could less upregulate PP2A activity than α-Syn monomers. Previous studies 
have shown the loss of PP2A activity was associated with α-Syn aggregation in DLB brain and 
α-Syn triplication brain, which was consistent with our findings.
A53T, the first point mutation related to PD, is prone to form aggregates by blocking 
the NAC domain to exhibit toxicity [9, 50]. In our study, we indeed confirmed A53T was 
Fig. 9. The residue I123 of PP2A Cα might 
play a role in its activity upregulation by α-Syn. 
(A) Schematic representation of I123, W200, 
L243, Y265 and C269 residues in PP2A Cα. 
(B) The purified PP2A Cα mutants (including 
I123S, W200S, L243S, Y265S and C269S) were 
detected by the CBB staining of SDS-PAGE 
gels. (C) GST pull-down assay was performed 
to detect the interaction between α-Syn and 
PP2A Cα mutants. Purified α-Syn protein were 
incubated with PP2A Cα mutant proteins, then 
the compounds were separated by SDS-PAGE 
gels. Anti-His and anti-GST blots showed input 
and pull-down fractions in GST pull-down assay. 
Input, PP2A Cα. (D) α-Syn and PP2A Cα I123S 
were incubated together, then PP2A activity 
was detected by colorimetric assay kit. *p<0.05, 
**p<0.01, n=5.
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more prone to aggregate than WT α-Syn 
using PCA, consequently we found A53T 
could less upregulate PP2A activity than 
WT α-Syn. Previous studies have shown 
that aging A53T mice exhibited α-Syn 
aggregation in olfactory and adrenal, and 
aggregated A53T α-Syn is a poor stimulator 
of PP2A activity [50], which was consistent 
with our findings. These data further 
suggested the NAC domain of α-Syn bound 
to PP2A Cα and upregulated its activity.
PP2A plays essential roles in 
neurodegenerative diseases. In PD, the 
upregulation of PP2A activity could reduce 
the TH phosphorylation to decrease the 
dopamine synthesis and increase the motor 
deficits. Since we found the NAC domain of 
α-Syn could bind to the hydrophobic center of PP2A Cα and upregulate its activity, blocking 
the NAC domain of α-Syn or occupying the hydrophobic center of PP2A Cα would be potential 
therapeutic methods of PD, since increasing the dopamine synthesis and alleviating the 
motor symptoms.
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